Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease

Platelets

Volumn 25, Issue 6, 2014, Pages 433-438

  Liang, Qing Cheng ^a   Jin, Di ^a   Li, Ying ^a   Wang, Rui Tao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Mean platelet volume; Platelet distribution width; Vascular dementia

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PLATELET DISTRIBUTION WIDTH; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION AND CHARACTERISTICS; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME; BLOOD; CLINICAL TRIAL; THROMBOCYTE;

AGED; ALZHEIMER DISEASE; BLOOD PLATELETS; CROSS-SECTIONAL STUDIES; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; MEAN PLATELET VOLUME; PLATELET COUNT;

EID: 84922713309     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.831064     Document Type: Article

References (33)

1. de la Torre JC. Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res Rev 2010;9:218-225.
2. Haag MD Hofman A Koudstaal PJ Stricker BH Breteler MM. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2009;80:13-17.
3. Borroni B Agosti C Marcello E Di LM Padovani A. Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol 2010;45:53-56.
4. Farias G Perez P Slachevsky A Maccioni RB. Platelet tau pattern correlates with cognitive status in Alzheimer's disease. J Alzheimers Dis 2012;31:65-69.
5. Forlenza OV Wacker P Nunes PV Yacubian J Castro CC Otaduy MC Gattaz WF. Reduced phospholipid breakdown in Alzheimer's brains: A 31P spectroscopy study. Psychopharmacology (Berl) 2005; 180:359-365.
6. Johnston JA Liu WW Coulson DT Todd S Murphy S Brennan S Foy CJ Craig D Irvine GB Passmore AP. Platelet beta-secretase activity is increased in Alzheimer's disease. Neurobiol Aging 2008; 29:661-668.
7. Forlenza OV Torres CA Talib LL de Paula VJ Joaquim HP Diniz BS Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. J Psychiatr Res 2011;45:220-224.
8. Stellos K Katsiki N Tatsidou P Bigalke B Laske C. Association of platelet activation with vascular cognitive impairment: Implications in dementia development. Curr Vasc Pharmacol 2012;10:1-3.
9. Laske C Sopova K Stellos K. Platelet activation in Alzheimer's disease: From pathophysiology to clinical value. Curr Vasc Pharmacol 2012;10:626-630.
10. Purandare N Burns A. Cerebral emboli in the genesis of dementia. J Neurol Sci 2009;283:17-20.
11. Purandare N Burns A Morris J Perry EP Wren J McCollum C. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia. Am J Psychiatry 2012;169:300-308.
12. Sakurai H Hanyu H Sato T Kume K Hirao K Kanetaka H Iwamoto T. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study. Geriatr Gerontol Int 2013;13:90-97.
13. Gasparyan AY Ayvazyan L Mikhailidis DP Kitas GD. Mean platelet volume: A link between thrombosis and inflammation. Curr Pharm Des 2011;17:47-58.
14. Kaito K Otsubo H Usui N Yoshida M Tanno J Kurihara E Matsumoto K Hirata R Domitsu K Kobayashi M. Platelet size deviation width platelet large cell ratio and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol 2005;128:698-702.
15. Wang RT Li Y Zhu XY Zhang YN. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011;22: 447-451.
16. Jans DM Martinet W Van De Parre TJ Herman AG Bult H Kockx MM De Meyer GR. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease. Cardiovasc Hematol Disord Drug Targets 2006;6:21-34.
17. Prodan CI Ross ED Stoner JA Cowan LD Vincent AS Dale GL. Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:247-252.
18. Prodan CI Szasz R Vincent AS Ross ED Dale GL. Coatedplatelets retain amyloid precursor protein on their surface. Platelets 2006;17:56-60.
19. Prodan CI Ross ED Vincent AS Dale GL. Differences in coated-platelet production between frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord 2009;23: 234-237.
20. Prodan CI Ross ED Vincent AS Dale GL. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol 2007;254:548-549.
21. Prodan CI Ross ED Vincent AS Dale GL. Rate of progression in Alzheimer's disease correlates with coated-platelet levels-A longitudinal study. Transl Res 2008;152:99-102.
22. Salmina AB Inzhutova AI Malinovskaya NA Petrova MM. Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control. J Alzheimers Dis 2010;22:17-36.
23. Gattaz WF Cairns NJ Levy R Forstl H Braus DF Maras A. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1996;246:129-131.
24. Krzystanek E Krzystanek M Opala G Trzeciak HI Siuda J Malecki A. Platelet phospholipase A2 activity in patients with Alzheimer's disease vascular dementia and ischemic stroke. J Neural Transm 2007;114:1033-1039.
25. Emmerling MR Moore CJ Doyle PD Carroll RT Davis RE. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. Biochem Biophys Res Commun 1993;197:292-297.
26. Borkataky S Jain R Gupta R Singh S Krishan G Gupta K Kudesia M. Role of platelet volume indices in the differential diagnosis of thrombocytopenia: A simple and inexpensive method. Hematology 2009;14:182-186.
27. Ginhoux F Greter M Leboeuf M Nandi S See P Gokhan S Mehler MF Conway SJ Ng LG Stanley ER et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330:841-845.
28. Boche D Nicoll JA. The role of the immune system in clearance of Abeta from the brain. Brain Pathol 2008;18:267-278.
29. Kaushansky K. Thrombopoietin. N Engl J Med 1998;339:746-754.
30. Gomez RM Moscato P. Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease. PLoS One 2008;3:e3111. doi:10.1371/journal.pone.0003111.
31. Lampron A Gosselin D Rivest S. Targeting the hematopoietic system for the treatment of Alzheimer's disease. Brain Behav Immun 2011;25(Suppl 1):S71-S79.
32. Wang RT Jin D Li Y Liang QC. Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease. J Psychiatr Res 2013;47: 644-649.
33. Liu R Gao F Huo J Yi Q. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease. Platelets 2012;23:11-16.